| Affiliation: | 1. Laboratory of Clinical Pharmacology, Dana Farber Cancer Institute, Boston, Massachusetts, U.S.A.;2. Joint Program in Nuclear Medicine, Harvard Medical School, Boston, Massachusetts, U.S.A.;3. Section of Nuclear Medicine, Department of Radiology, Duke University Medical Center, Durham, N.C., U.S.A.;2. DECN - Departamento de Engenharia e Ciências Nucleares, Instituto Superior Técnico, Universidade de Lisboa, Portugal;3. Department of Nuclear Medicine and Molecular Imaging, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland;4. LAbCore, Ludwig Institute for Cancer Research, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland;5. Ludwig Institute for Cancer Research and Department of Oncology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland |
